Irbesartan and Hydrochlorothiazide
- Product NDC
- 70518-3593
- 11-digit product format
- 705183593
- Labeler code
- 70518
- Product ID
- 70518-3593_f0d1884b-cc92-bbdc-e053-2a95a90a02e6
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Irbesartan and Hydrochlorothiazide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA203072
- Marketing category
- ANDA
- Marketing start
- 2022-12-12
- Marketing end
- 0000-00-00
- Substance
- HYDROCHLOROTHIAZIDE; IRBESARTAN
- Active strength
- 13 mg/1; mg/1
- Pharmacologic classes
- Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 70518-3593-0 | Irbesartan and Hydrochlorothiazide | 90 in 1 BOTTLE, PLASTIC | TABLET | 90 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 70518-3593 | IRBESARTAN AND HYDROCHLOROTHIAZIDE TABLET [REMEDYREPACK INC.] | 1 | Legacy NDC, 1 package rows | 20221228_89b8360b-2e30-4ad1-b7b6-df0866f58a22.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-3593-0 | 70518359300 | 90 TABLET in 1 BOTTLE, PLASTIC (70518-3593-0) | 90 tablet | 2022-12-12 | 0000-00-00 | No | No | Current |